Innovent Biologics Inc. ADR (IVBIY)
Market Closed
16 Jul, 20:00
OTC PINK OTC PINK Primary $
44. 11
0
0%
$
19.2B Market Cap
- P/E Ratio
- Div Yield
200 Volume
0 Eps
$ 44.11
Previous Close Want to track IVBIY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Innovent Biologics Inc. ADR (IVBIY) Statistics
Valuation metrics
Market Cap 19.2B
Enterprise value 9B
Trailing P/E (ttm) 157.68
Forward P/E -
PEG ratio -
Price/Sales (ttm) 1.47
Price/Book (mrq) 6.66
Enterprise Value/Revenue 4.69
Enterprise Value/EBITDA 46.69
Overview
Shares outstanding 1.73B
Float 1.61B
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 13
Average volume (90 days) 15
Price summary
52-Week low 37.54
52-Week high 52
Beta 0.24
50-Day moving average 43.34
200-Day moving average 44.53
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.06%
Operating margin -0.01%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.05%
Income Statement
Revenue (ttm) 1.92B
Revenue per share (ttm) 31.1
Quarterly revenue growth (yoy) 0.3%
Gross profit (ttm) 1.47B
EBITDA 1.52B
Net income to common (ttm) 119.72M
Diluted EPS (ttm) 0.28
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 2.68B
Total cash per share (mrq) 10.51
Total debt (mrq) 414.34M
Total Debt/Equity (mrq) 14.55
Current ratio (mrq) 2.62%
Book value per share (mrq) 6.63
Cash Flow
Cash flow statement 1.47B
Levered free cash flow (LFCF) 475.02M
